InsiderFlow

Michael A Metzger

SNDX

Michael A Metzger serves as director, officer: Chief Executive Officer at Syndax Pharmaceuticals, Inc. (SNDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

18 trades

$12.17M

Net Position

Net Seller

$12.17M

Companies Traded

1

SNDX

Active Period

Sep 2021 – Feb 2026

18 total trades

Most Recent

Sell SNDX

Feb 10, 2026 · $360.8K

Michael A Metzger's Insider Trading at Syndax Pharmaceuticals, Inc. (SNDX)

Buys

0 · $0.00

Sells

18 · $12.17M

Total Shares Bought

0

Total Shares Sold

635,343

SNDX Price Chart
Loading chart...
DateTypeValue
Feb 10, 2026 Sell$360.8K
Feb 9, 2026 Sell$360.8K
Feb 4, 2026 Sell$152.8K
Sep 8, 2025 Sell$2.58M
Jul 16, 2025 Sell$70.0K
Mar 4, 2025 Sell$117.6K
Feb 12, 2025 Sell$206.0K
Feb 8, 2023 Sell$164.7K
Oct 7, 2022 Sell$410.5K
Oct 4, 2022 Sell$844.9K
Jul 27, 2022 Sell$665.4K
Jul 8, 2022 Sell$318.4K
Dec 20, 2021 Sell$1.70M
Dec 15, 2021 Sell$697.5K
Oct 27, 2021 Sell$1.17M
Sep 28, 2021 Sell$476.8K
Sep 22, 2021 Sell$702.9K
Sep 15, 2021 Sell$1.17M